IDDM: an islet or an immune disease?
Insulin-dependent diabetes develops as a consequence of the selective destruction of insulin-producing cells by an autoimmune reaction. However, the precise series of events which trigger anti-islet autoreactive T cells is still being investigated. Major issues will need to be raised before a comprehensive view of the anti-islet autoimmune reaction can be delineated. These include defining the primary site of activation of autoreactive lymphocytes and exploring hypotheses to explain the chronicity of the diabetes process. These issues all relate with the more general dilemma of the actual role of the islets of Langerhans in breaking self tolerance to beta-cell antigens. By studying non-obese diabetic mice deprived of beta cells following a single injection of a high dose of alloxan at 3 weeks of age, we recently obtained evidence that the activation of autoreactive T cells requires the presence of target islet cells in order to develop.
Boitard
C
C
INSERM U25, Hôpital Necker, Paris, France.
Larger
E
E
Timsit
J
J
Sempe
P
P
Bach
J F
JF
D000818:Animals; D001327:Autoimmune Diseases; D001363:Awards and Prizes; D003920:Diabetes Mellitus / Q000266:history; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000276:immunology* / Q000503:physiopathology*; D004777:Environment; D005060:Europe; D005602:France; D049673:History, 20th Century; D007515:Islets of Langerhans / Q000503:physiopathology*; D008213:Lymphocyte Activation; D008297:Male; D012955:Societies, Medical; D013601:T-Lymphocytes / Q000276:immunology; D014777:Virus Diseases / Q000150:complications